New Depression Treatment Trial Begins with First Patient Dosed
Seaport Therapeutics has started its phase 2b BUOY-1 trial for GlyphAllo, a new oral medication for major depressive disorder (MDD), […]
Seaport Therapeutics has started its phase 2b BUOY-1 trial for GlyphAllo, a new oral medication for major depressive disorder (MDD), […]
The biotech world is going through a tough time right now. So far this year, big companies buying smaller ones
A recent study has found that a new type of medication may be effective in managing chronic pain. This new
A recently conducted study revealed that a new medication, known as Inclisiran, has shown promising results in lowering cholesterol levels.
There’s good news for those managing high cholesterol levels. A new drug has been shown to significantly reduce ‘bad’ cholesterol,
Several exciting updates are happening in the world of pharmaceuticals! Here’s a simple breakdown: 1. **Improving Drug Absorption**: There’s a
A recent study published in the journal ‘Family Practice’ reveals that many doctors are still prescribing antibiotics for common colds,